胸部外科手術の世界市場2019-2023

【英語タイトル】Global Thoracic Surgery Market 2019-2023

Technavioが出版した調査資料(IRTNTR31514)・商品コード:IRTNTR31514
・発行会社(調査会社):Technavio
・発行日:2019年6月17日
・ページ数:152
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:アジア、ヨーロッパ、北米、その他
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥262,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥315,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥420,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Technavio社の本調査レポートでは、胸部外科手術の世界市場について調べ、胸部外科手術の市場状況、市場規模、市場予測、市場環境、顧客状況、市場動向、関連企業情報などをまとめました。また、胸部外科手術の市場規模をセグメンテーション別(製品別(CRM・心臓補助装置、心臓弁修復・交換装置、心肺装置、心臓欠陥閉鎖装置、その他の胸部手術装置)、)と地域別(アジア、ヨーロッパ、北米、その他)に分けて算出しました。Technavio社は胸部外科手術の世界市場規模が2019-2023期間中に年平均9%成長すると予測しています。
・サマリー
・レポートの範囲
・胸部外科手術の市場状況
・胸部外科手術の市場規模
・胸部外科手術の市場予測
・胸部外科手術の世界環境:ファイブフォース分析
・市場セグメンテーション:製品別(CRM・心臓補助装置、心臓弁修復・交換装置、心肺装置、心臓欠陥閉鎖装置、その他の胸部手術装置)
・胸部外科手術の顧客状況
・主要地域別市場規模:アジア、ヨーロッパ、北米、その他
・意思決定フレームワーク
・市場動向・成長要因・課題
・関連企業状況・企業分析
 ...
【レポートの概要】

Global Thoracic Surgery Market: About this market

Thoracic surgery is an operation performed for treating conditions of the chest organs, including the heart, lungs, esophagus, and trachea. Technavio’s thoracic surgery market analysis considers the revenues generated from products such as CRM and cardiac assist devices, heart valve repair and replacement devices, cardiopulmonary devices, heart defect closure devices, and other thoracic surgery devices. Our analysis also considers the sales of thoracic surgery in North America, Europe, Asia, and ROW. In 2018, the CRM and cardiac assist devices segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the increasing prevalence of cardiac arrhythmia will play a significant role in the CRM and cardiac assist devices segment to maintain its market position. Our global thoracic surgery market report looks at factors such as the increasing prevalence of CVDs and lung diseases, growing awareness initiatives and access to healthcare, and technological advances and new product launches. However, the high cost of thoracic surgeries and devices, stringent regulations, and shortage of skilled thoracic surgeons may hamper the growth of the thoracic surgery industry over the forecast period.

Global thoracic surgery market: Overview

Technological advances and new product launches

The global thoracic surgery market is witnessing several technological advancements in both MI surgeries and open procedures. Technological advancements in endoscopy have led to the development of ultra-MI thoracic procedures, which can be performed on patients with the benign esophageal disease and early-stage esophageal cancer. Thus, significant advances in devices will fuel the demand for thoracic surgeries, thereby, driving the growth of the market at a CAGR of more than 9% during the forecast period.

Increasing number of thoracic surgeries

The demand for thoracic surgeries has increased significantly among patients with severe comorbid conditions. This is mainly due to technological advancements in thoracic surgery devices along with improved experience and confidence of surgeons to operate on high-risk individuals. Furthermore, the increase recommendations by health organizations promoting the use of these devices are also propelling the demand for thoracic surgery. Thus, the increasing number of thoracic surgeries is identified as a key trend that will impact the growth of the market during the forecast period.

For the detailed list of factors that will drive the global thoracic surgery market during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of few major players, the global thoracic surgery market is concentrated. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading thoracic surgery providers, that include Abbott Laboratories, Boston Scientific Corp., Edwards Lifesciences Corp., LivaNova Plc, and Medtronic Plc.

Also, the thoracic surgery market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

2.1 Preface

2.2 Preface

2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

Market segmentation by product

Comparison by product

CRM and cardiac assist devices – Market size and forecast 2018-2023

Heart valve repair and replacement devices –

Market size and forecast 2018-2023

Cardiopulmonary devices – Market size and forecast 2018-2023

Heart defect closure devices – Market size and forecast 2018-2023

Other thoracic surgery devices – Market size and forecast 2018-2023

Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

North America – Market size and forecast 2018-2023

Europe – Market size and forecast 2018-2023

Asia – Market size and forecast 2018-2023

ROW – Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 11: MARKET TRENDS

Strategic acquisitions

Increasing number of thoracic surgeries

Increasing focus on robotic surgeries

PART 12: VENDOR LANDSCAPE

Overview

Landscape disruption

PART 13: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

Abbott Laboratories

Boston Scientific Corp.

Edwards Lifesciences Corp.

LivaNova Plc

Medtronic Plc

PART 14: APPENDIX

Research methodology

List of abbreviations

Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

LOE

Exhibit 01: Global medical devices market

Exhibit 02: Segments of global medical devices market

Exhibit 03: Market characteristics

Exhibit 04: Market segments

Exhibit 05: Market definition – Inclusions and exclusions checklist

Exhibit 06: Market size 2018

Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)

Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)

Exhibit 09: Five forces analysis 2018

Exhibit 10: Five forces analysis 2023

Exhibit 11: Bargaining power of buyers

Exhibit 12: Bargaining power of suppliers

Exhibit 13: Threat of new entrants

Exhibit 14: Threat of substitutes

Exhibit 15: Threat of rivalry

Exhibit 16: Market condition – Five forces 2018

Exhibit 17: Product – Market share 2018-2023 (%)

Exhibit 18: Comparison by product

Exhibit 19: CRM and cardiac assist devices – Market size and forecast 2018-2023 ($ millions)

Exhibit 20: CRM and cardiac assist devices – Year-over-year growth 2019-2023 (%)

Exhibit 21: Heart valve repair and replacement devices – Market size and forecast 2018-2023 ($ millions)

Exhibit 22: Heart valve repair and replacement devices – Year-over-year growth 2019-2023 (%)

Exhibit 23: Cardiopulmonary devices – Market size and forecast 2018-2023 ($ millions)

Exhibit 24: Cardiopulmonary devices – Year-over-year growth 2019-2023 (%)

Exhibit 25: Heart defect closure devices – Market size and forecast 2018-2023 ($ millions)

Exhibit 26: Heart defect closure devices – Year-over-year growth 2019-2023 (%)

Exhibit 27: Other thoracic surgery devices – Market size and forecast 2018-2023 ($ millions)

Exhibit 28: Other thoracic surgery devices – Year-over-year growth 2019-2023 (%)

Exhibit 29: Market opportunity by product

Exhibit 30: Customer landscape

Exhibit 31: Market share by geography 2018-2023 (%)

Exhibit 32: Geographic comparison

Exhibit 33: North America – Market size and forecast 2018-2023 ($ millions)

Exhibit 34: North America – Year-over-year growth 2019-2023 (%)

Exhibit 35: Europe – Market size and forecast 2018-2023 ($ millions)

Exhibit 36: Europe – Year-over-year growth 2019-2023 (%)

Exhibit 37: Asia – Market size and forecast 2018-2023 ($ millions)

Exhibit 38: Asia – Year-over-year growth 2019-2023 (%)

Exhibit 39: ROW – Market size and forecast 2018-2023 ($ millions)

Exhibit 40: ROW – Year-over-year growth 2019-2023 (%)

Exhibit 41: Key leading countries

Exhibit 42: Market opportunity

Exhibit 43: Impact of drivers and challenges

Exhibit 44: Cardiac devices new implant rates per 100,000 population between 2010 and 2015

Exhibit 45: Number of CABG procedures performed between 2010 and 2016 in various countries

Exhibit 46: Vendor landscape

Exhibit 47: Landscape disruption

Exhibit 48: Vendors covered

Exhibit 49: Vendor classification

Exhibit 50: Market positioning of vendors

Exhibit 51: Abbott Laboratories – Vendor overview

Exhibit 52: Abbott Laboratories – Business segments

Exhibit 53: Abbott Laboratories – Organizational developments

Exhibit 54: Abbott Laboratories – Geographic focus

Exhibit 55: Abbott Laboratories – Segment focus

Exhibit 56: Abbott Laboratories – Key offerings

Exhibit 57: Abbott Laboratories – Key customers

Exhibit 58: Boston Scientific Corp. – Vendor overview

Exhibit 59: Boston Scientific Corp. – Business segments

Exhibit 60: Boston Scientific Corp. – Organizational developments

Exhibit 61: Boston Scientific Corp. – Geographic focus

Exhibit 62: Boston Scientific Corp. – Segment focus

Exhibit 63: Boston Scientific Corp. – Key offerings

Exhibit 64: Boston Scientific Corp. – Key customers

Exhibit 65: Edwards Lifesciences Corp. – Vendor overview

Exhibit 66: Edwards Lifesciences Corp. – Product segments

Exhibit 67: Edwards Lifesciences Corp. – Organizational developments

Exhibit 68: Edwards Lifesciences Corp. – Geographic focus

Exhibit 69: Edwards Lifesciences Corp. – Segment focus

Exhibit 70: Edwards Lifesciences Corp. – Key offerings

Exhibit 71: Edwards Lifesciences Corp. – Key customers

Exhibit 72: LivaNova Plc – Vendor overview

Exhibit 73: LivaNova Plc – Business segments

Exhibit 74: LivaNova Plc – Organizational developments

Exhibit 75: LivaNova Plc – Geographic focus

Exhibit 76: LivaNova Plc – Segment focus

Exhibit 77: LivaNova Plc – Key offerings

Exhibit 78: LivaNova Plc – Key customers

Exhibit 79: Medtronic Plc – Vendor overview

Exhibit 80: Medtronic Plc – Business segments

Exhibit 81: Medtronic Plc – Organizational developments

Exhibit 82: Medtronic Plc – Geographic focus

Exhibit 83: Medtronic Plc – Segment focus

Exhibit 84: Medtronic Plc – Key offerings

Exhibit 85: Medtronic Plc – Key customers

Exhibit 86: Validation techniques employed for market sizing

Exhibit 87: Definition of market positioning of vendors



【掲載企業】

Abbott Laboratories
Boston Scientific Corp.
Edwards Lifesciences Corp.
LivaNova Plc
Medtronic Plc

★調査レポート[胸部外科手術の世界市場2019-2023] (コード:IRTNTR31514)販売に関する免責事項を必ずご確認ください。
★調査レポート[胸部外科手術の世界市場2019-2023]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆